Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium

**Who it affects:** - Biopharmaceutical companies that join this consortium - The broader pharmaceutical manufacturing industry - Potentially patients who rely on medications produced by these companies **What would change:** The participating companies would be able to collaborate on manufacturing preparedness activities - likely planning how to quickly scale up production of medications during emergencies or shortages. Under the 1993 law, these companies receive some protection from certain antitrust lawsuits when they cooperate for research and production purposes, as long as they follow specific rules. This appears aimed at improving the pharmaceutical industry's ability to respond to public health emergencies by allowing coordinated planning and cooperation.